Valuation (7%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -6.95 | N/A |
| PEG Ratio (TTM) | -0.22 | N/A |
| P/S Ratio (TTM) | 2.42 | N/A |
| P/B Ratio (TTM) | -10.16 | N/A |
| P/FCF Ratio (TTM) | -0.67 | N/A |
| Price to 5YR AVG Earnings Ratio | -4.39 | N/A |
| Price to 5YR AVG FCF Ratio | -1.15 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -93.53% | N/A |
| ROE (TTM) | 136.62% | N/A |
| Net Profit Margin (TTM) | -502.92% | N/A |
| ROIC 5YR AVG | -132.35% | N/A |
Growth (33%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 33.45% | -25,189.13% | -15,133.23% |
| Revenue | -0.54% | 49.15% | 49.26% |
| Net Income | 30.48% | -147,052.05% | -88,254.33% |
| Cash Flow | -3.67% | -16,387.04% | -9,844.04% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.01 | N/A |
| Quick Ratio (TTM) | 2.81 | N/A |
| D/E Ratio (TTM) | -2.13 | N/A |
| Interest Coverage (TTM) | -25.44 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -4.12 | N/A |
| Shares Outstanding Growth 5YR AVG | 128.59% | N/A |